GlassScriptPhysician profile
Lance S Cassell
NPI 1205058328
$2,077.47
in general payments reported to CMS, 2019-2025
31 companies · $238 in 2025
The $238 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $817 · 2020: $219 · 2021: $206 · 2022: $297 · 2023: $125 · 2024: $175 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $537.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $491.67 | 2019-2025 | Xtampza |
| Boston Scientific Corporation | $306.32 | 2020-2025 | General - Pain Management, Intracept |
| Pfizer INC. | $181.39 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $143.87 | 2019-2022 | |
| Protega Pharmaceutials INC | $107.29 | 2022-2023 | Roxybond |
| Tersera Therapeutics LLC | $84.86 | 2019 | |
| Abbvie INC. | $68.64 | 2022-2023 | Ubrelvy |
| Grt US Holding, INC. | $56.00 | 2022 | |
| Kaleo, INC. | $55.44 | 2019 | |
| Ibsa Pharma INC. | $53.01 | 2021-2022 | |
| Redhill Biopharma INC. | $51.22 | 2020-2021 | |
| Scilex Pharmaceuticals INC. | $42.49 | 2019-2022 | |
| Amgen INC. | $42.37 | 2019 | |
| Daiichi Sankyo INC. | $40.19 | 2019 | |
| Assertio Therapeutics, INC. | $38.64 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $34.86 | 2019 | |
| Mdd US Operations, LLC | $25.35 | 2019 | |
| Convatec INC. | $23.97 | 2025 | |
| Biodelivery Sciences International, INC. | $23.89 | 2019 | |
| Relievant Medsystems, INC. | $21.54 | 2023 | Intracept |
| West Therapeutics Development, LLC | $20.69 | 2019 | |
| Electronic Waveform Lab, INC. | $19.38 | 2019 | |
| Avanos Medical | $18.85 | 2024 | Standard Rf Disposables |
| Arbor Pharmaceuticals, INC. | $18.75 | 2020 | |
| Novartis Pharmaceuticals Corporation | $18.65 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $18.39 | 2023 | Seglentis |
| Nalu Medical, INC. | $15.34 | 2021 | |
| Curonix LLC | $15.23 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Fidia Pharma USA INC. | $14.66 | 2023 | Triluron, Hymovis |
| Hikma Pharmaceuticals USA | $12.95 | 2022 | |
| Zyla Life Sciences, INC. | $11.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Cassell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.